Financial Snapshot

Revenue
$981.1K
TTM
Gross Margin
-676.57%
TTM
Net Earnings
-$12.15M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
13.69%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$9.788M
Q3 2024
Cash
Q3 2024
P/E
-0.3430
Nov 29, 2024 EST
Free Cash Flow
$368.4K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue $2.156M $6.686M $4.604M $1.710M $2.306M $668.6K $122.8K $95.15K $110.4K $21.20K $20.00K
YoY Change -67.76% 45.22% 169.28% -25.84% 244.83% 444.68% 29.01% -13.84% 420.9% 6.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue $2.156M $6.686M $4.604M $1.710M $2.306M $668.6K $122.8K $95.15K $110.4K $21.20K $20.00K
Cost Of Revenue $1.797M $4.071M $1.612M $278.1K $598.6K $405.5K $44.47K $0.00
Gross Profit $358.7K $2.614M $2.992M $1.432M $1.707M $263.1K $78.28K $0.00
Gross Profit Margin 16.64% 39.11% 64.99% 83.74% 74.04% 39.35% 63.77% 0.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Selling, General & Admin $4.749M $926.7K $675.3K $6.535M $3.432M $650.0K $436.7K $1.518M $1.530K $180.0K
YoY Change 412.45% 37.23% 90.39% 428.02% 48.85% -71.24% 99132.68% -99.15%
% of Gross Profit 1323.93% 35.45% 22.57% 382.85% 1304.72% 830.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.400M $1.408M $542.4K $783.3K $231.9K $5.470K $7.200K $7.240K $6.170K $400.00 $0.00
YoY Change -0.58% 159.62% -30.76% 237.82% 4138.94% -24.03% -0.55% 17.34% 1442.5%
% of Gross Profit 390.3% 53.86% 18.13% 54.71% 13.58% 2.08% 9.2%
Operating Expenses $7.845M $16.78M $13.26M $8.968M $7.599M $3.679M $791.1K $506.7K $1.685M $47.84K $490.0K
YoY Change -53.25% 26.58% 47.83% 18.02% 106.57% 365.05% 56.12% -69.92% 3421.57% -90.24%
Operating Profit -$7.486M -$14.17M -$10.27M -$7.537M -$5.892M -$3.416M -$712.8K -$47.84K
YoY Change -47.16% 38.01% 36.21% 27.91% 72.51% 379.22%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Interest Expense -$2.511M $902.1K -$2.102M -$934.7K -$6.270K $1.338M -$279.2K -$56.23K -$48.67K $0.00 -$10.00K
YoY Change -378.32% -142.91% 124.91% 14807.18% -100.47% -579.17% 396.53% 15.55% -100.0%
% of Operating Profit
Other Income/Expense, Net $269.4K -$755.2K $2.990K -$404.1K $0.00 -$649.3K -$191.6K $0.00
YoY Change -135.67% -25358.7% -100.74% -100.0% 238.95%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Pretax Income -$9.728M -$14.92M -$12.17M -$8.876M -$5.899M -$4.112M -$2.140M -$665.1K -$3.592M -$26.64K -$480.0K
YoY Change -34.81% 22.64% 37.1% 50.47% 43.44% 92.19% 221.74% -81.48% 13382.43% -94.45%
Income Tax $9.600K $793.00 $1.080K $3.300K $2.080K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.737M -$14.92M -$12.17M -$8.879M -$5.901M -$4.112M -$2.140M -$665.1K -$3.592M -$26.64K -$480.0K
YoY Change -34.75% 22.64% 37.06% 50.47% 43.49% 92.19% 221.74% -81.48% 13382.43% -94.45%
Net Earnings / Revenue -451.7% -223.23% -264.33% -519.33% -255.94% -615.06% -1743.15% -698.95% -3252.49% -125.66% -2400.0%
Basic Earnings Per Share -$0.77 -$4.18 -$9.06
Diluted Earnings Per Share -$0.77 -$4.18 -$9.060M -$37.68M -$43.00M -$67.11M -$58.33M -$20.56M -$5.024M -$149.60 -$6.327K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Cash & Short-Term Investments $34.01K $73.19K $449.0K $457.8K $46.54K $807.8K $1.650K $30.19K $18.37K $100.5K $10.00K
YoY Change -53.53% -83.7% -1.92% 883.67% -94.24% 48854.55% -94.53% 64.34% -81.72% 904.8%
Cash & Equivalents $34.01K $73.19K $449.0K $457.8K $46.54K $807.8K $1.650K $30.19K $18.37K $100.5K $10.00K
Short-Term Investments
Other Short-Term Assets $4.140K $21.02K $1.630K $8.150K $1.280M $210.4K $64.91K $2.500K $39.67K $0.00 $0.00
YoY Change -80.3% 1189.57% -80.0% -99.36% 508.46% 224.06% 2496.4% -93.7%
Inventory $1.620M $2.024M $2.553M $345.0K $784.5K $87.10K $9.830K $0.00
Prepaid Expenses
Receivables $3.723M $6.586M $3.647M $2.003M $1.252M $39.17K $6.080K $13.74K $24.47K $0.00 $0.00
Other Receivables $0.00 $0.00 $2.900K $2.900K $24.27K $0.00 $75.00K $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $5.381M $8.704M $6.654M $2.817M $3.387M $1.144M $157.5K $46.44K $82.52K $100.5K $10.00K
YoY Change -38.18% 30.82% 136.21% -16.83% 195.95% 626.72% 239.08% -43.72% -17.87% 904.8%
Property, Plant & Equipment $4.401M $6.569M $9.273M $1.053M $1.172M $59.62K $11.15K $14.38K $17.64K $0.00 $0.00
YoY Change -33.0% -29.16% 780.51% -10.16% 1866.15% 434.71% -22.46% -18.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change
Other Assets $248.6K $178.9K $178.9K $41.60K $1.201M $2.414M $11.69K $11.69K $11.69K $0.00 $0.00
YoY Change 38.91% 0.0% 330.12% -96.54% -50.25% 20553.89% 0.0% 0.0%
Total Long-Term Assets $4.745M $6.855M $9.821M $1.095M $3.827M $2.549M $61.84K $90.54K $97.78K $3.540K $0.00
YoY Change -30.78% -30.2% 797.1% -71.4% 50.13% 4022.43% -31.7% -7.4% 2662.15%
Total Assets $10.13M $15.56M $16.47M $3.912M $7.214M $3.694M $219.3K $137.0K $180.3K $104.0K $10.00K
YoY Change
Accounts Payable $1.945M $3.140M $1.163M $153.6K $226.5K $73.06K $143.3K $54.71K $37.42K $82.38K $80.00K
YoY Change -38.06% 169.96% 657.15% -32.16% 209.98% -49.01% 161.87% 46.21% -54.58% 2.98%
Accrued Expenses $254.4K $833.9K $3.216M $244.0K $244.2K $112.5K $161.3K $185.9K $31.59K $0.00
YoY Change -69.49% -74.07% 1217.93% -0.08% 117.01% -30.23% -13.21% 488.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $35.00K $19.21K $193.5K $58.32K $8.000K $0.00 $10.00K
YoY Change -100.0% 82.2% -90.07% 231.79% 629.0% -100.0%
Long-Term Debt Due $8.569M $7.951M $4.866M $1.828M
YoY Change 7.78% 63.41% 166.25%
Total Short-Term Liabilities $11.13M $12.42M $9.463M $2.225M $505.7K $204.8K $1.949M $651.6K $77.01K $84.83K $150.0K
YoY Change -10.43% 31.29% 325.27% 340.04% 146.92% -89.49% 199.15% 746.08% -9.22% -43.45%
Long-Term Debt $0.00 $0.00 $0.00 $194.9K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $438.1K $1.392M $15.49K $59.00K
YoY Change -100.0% -68.53% 8886.89% -73.75%
Total Long-Term Liabilities $0.00 $438.1K $1.392M $210.4K $59.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -68.53% 561.54% 256.66%
Total Liabilities $11.13M $12.86M $10.86M $2.436M $564.7K $204.8K $1.949M $651.6K $77.01K $84.83K $150.0K
YoY Change -13.48% 18.49% 345.69% 331.33% 175.73% -89.49% 199.15% 746.08% -9.22% -43.45%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Basic Shares Outstanding 12.59M shares 3.570M shares 1.343M shares
Diluted Shares Outstanding 12.59M shares 3.570M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $4.1664 Million

About Can B Corp

Can B Corp. engages in the business of promoting health and wellness through developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass, and the licensing of durable medical devices. The company is headquartered in Hicksville, New York and currently employs 12 full-time employees. The company went IPO on 2011-03-11. The firm is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. The company develops its own line of proprietary products, as well as seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The firm is also focuses on protecting and commercializing the cannabis patents covering liquid formulations of cannabis.

Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries Peers: Enveric Biosciences, Inc. AmeriCann, Inc. CNS Pharmaceuticals, Inc. KIORA PHARMACEUTICALS INC GREEN HYGIENICS HOLDINGS INC. JOHNSON & JOHNSON RANGE IMPACT, INC. PALISADE BIO, INC. One World Products, Inc.